Survodutide
A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Microgynon® (Reference treatment (R)) followed by BI 456906 and Microgynon® (Test treatment (T)) | Healthy | n/r | n/r | n/r | n/r |